Revvity, Inc. (NYSE:RVTY) Shares Sold by Alliancebernstein L.P.

Alliancebernstein L.P. cut its stake in Revvity, Inc. (NYSE:RVTY - Free Report) by 86.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 132,084 shares of the company's stock after selling 850,921 shares during the quarter. Alliancebernstein L.P. owned about 0.11% of Revvity worth $14,742,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Assetmark Inc. grew its position in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after acquiring an additional 259 shares during the last quarter. Millstone Evans Group LLC bought a new stake in Revvity during the 4th quarter valued at about $38,000. Continuum Advisory LLC boosted its position in Revvity by 2,972.7% in the 3rd quarter. Continuum Advisory LLC now owns 338 shares of the company's stock valued at $43,000 after buying an additional 327 shares during the period. MassMutual Private Wealth & Trust FSB grew its stake in Revvity by 55.9% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 385 shares of the company's stock worth $43,000 after acquiring an additional 138 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in shares of Revvity by 33.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company's stock worth $58,000 after acquiring an additional 131 shares during the period. Institutional investors own 86.65% of the company's stock.

Revvity Stock Performance

NYSE RVTY traded up $0.73 during trading hours on Monday, reaching $95.59. The stock had a trading volume of 90,743 shares, compared to its average volume of 882,741. Revvity, Inc. has a 52-week low of $89.61 and a 52-week high of $129.50. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. The stock has a market cap of $11.49 billion, a P/E ratio of 43.26, a price-to-earnings-growth ratio of 3.82 and a beta of 1.07. The stock has a fifty day moving average of $109.12 and a 200 day moving average of $115.09.

Remove Ads

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share for the quarter, topping analysts' consensus estimates of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period last year, the company earned $1.25 EPS. Sell-side analysts predict that Revvity, Inc. will post 4.94 earnings per share for the current year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Friday, April 18th will be paid a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Thursday, April 17th. Revvity's dividend payout ratio is currently 12.67%.

Analyst Ratings Changes

A number of analysts recently issued reports on RVTY shares. Sanford C. Bernstein lowered Revvity from an "outperform" rating to a "market perform" rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Barclays lowered their target price on Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a report on Thursday. KeyCorp raised their price target on Revvity from $132.00 to $145.00 and gave the company an "overweight" rating in a research note on Monday, February 3rd. Finally, Raymond James reaffirmed an "outperform" rating and issued a $145.00 price objective (up from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Four research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $133.75.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 15,170 shares of the firm's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $126.73, for a total value of $1,922,494.10. Following the transaction, the insider now directly owns 33,400 shares of the company's stock, valued at approximately $4,232,782. This trade represents a 31.23 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.68% of the stock is owned by company insiders.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.